As a company listed on the Euronext Growth market in Paris, Europlasma undertakes to providing the financial community with regular, transparent and accessible information and in compliance with stock market regulations
Pursuant to the terms of the 10th resolution approved by the shareholders at the Extraordinary General Meeting of June 24, 2015, and expiring on August 23, 2017, Europlasma today issued 3 100 477 new ordinary shares by private placement. The subscription was released by compensation with 823 K€ of liquid and payable debts.
